头颈癌患者低骨骼肌质量与全身炎症同微血管皮瓣重建术后手术并发症及生存的关联
研究纳入554例接受微血管游离皮瓣重建的头颈癌患者,测量骨骼肌质量(SMM)与中性粒细胞与淋巴细胞比值(NLR)并分析其与治疗结局的关联。结果显示,NLR升高是全皮瓣类型并发症的预测因素(OR 1.5),低SMM预测桡前臂皮瓣并发症(OR 2.0),NLR升高合并低SMM预测腓骨皮瓣手术并发症(OR 4.3)。结论认为SMM与NLR可预测接受微血管重建头颈癌患者的不良结局。
要点
- NLR升高与所有皮瓣类型术后并发症相关(OR 1.5)。
- 低SMM与桡前臂皮瓣并发症相关(OR 2.0),NLR升高合并低SMM与腓骨皮瓣并发症相关(OR 4.3)。
- 早期头颈癌中,低SMM(HR 2.3)及NLR升高合并低SMM(HR 2.6)为总生存下降的预后因素。
核心结论
- SMM与NLR可预测接受微血管重建的头颈癌患者的不良结局。
研究设计与样本
- 纳入接受微血管游离皮瓣重建的头颈癌患者,测量SMM与NLR并分析其与治疗结局的关联,共554例患者。
主要发现
- 所有皮瓣类型中,NLR升高是并发症的预测因素(OR 1.5)。
- 桡前臂皮瓣手术中,低SMM是并发症的预测因素(OR 2.0)。
- 腓骨皮瓣手术中,NLR升高合并低SMM是并发症的预测因素(OR 4.3)。
- 仅有NLR升高的患者有皮瓣相关并发症风险(OR 3.0)和严重并发症风险(OR 2.2);NLR升高合并低SMM与住院时间延长相关(+3.9天)。
- 早期头颈癌中,低SMM(HR 2.3)及NLR升高合并低SMM(HR 2.6)为总生存下降的预后因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Skeletal muscle mass (SMM) and chronic inflammation are associated with postoperative complications and survival. METHODS: Patients with head and neck cancer (HNC) undergoing microvascular free flap reconstruction were included. SMM and neutrophil-to-lymphocyte ratio (NLR) were measured and their association with treatment outcomes analyzed. RESULTS: Five hundred and fifty-four patients were included. Predictors for complications were elevated NLR in all flaps (OR 1.5), low SMM in radial forearm flap (OR 2.0), and elevated NLR combined with low SMM in fibula flap surgery (OR 4.3). Patients with solely elevated NLR were at risk for flap-related complications (OR 3.0), severe complications (OR 2.2), and when combined with low SMM for increased length of hospital stays (LOS) (+3.9 days). In early-stage HNC, low SMM (HR 2.3), and combined elevated NLR with low SMM (HR 2.6) were prognostics for decreased overall survival. CONCLUSIONS: SMM and NLR are predictive for poor outcomes in patients with HNC undergoing microvascular reconstruction.
引用
- Chargi N, Breik O, Forouzanfar T, et al. Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer. Head Neck. 2022. PMID: 35652420. doi:10.1002/hed.27113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。